Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Sales $ 425,597 $ 275,039
Cost of sales (238,127) (159,466)
Gross profit 187,470 115,573
Operating Expenses    
Selling and marketing 171,820 116,516
General and administrative 1,745,234 1,357,997
Depreciation and amortization 46,219 36,930
Total operating expenses 1,963,273 1,511,443
Loss From Operations (1,775,803) (1,395,870)
Other Expense (Income)    
Interest expense, net 754,220 5,979
Forgiveness of PPP loan (242,486)
Other income (75,000)
Gains from foreign currency translation (182,922) (19,003)
Total other (income) expense 496,298 (255,510)
Net Loss (2,272,101) (1,140,360)
Net loss attributable to non-controlling interest 72,261 27,509
Net Loss Attributable to Common Stockholders $ (2,199,840) $ (1,112,851)
Net Loss Per Common Share    
Basic and Diluted $ (0.21) $ (0.18)
Weighted Average Number of Common Shares Outstanding    
Basic and Diluted 10,437,585 6,343,134